This Investment Strategy Has Been Foolproof Since 1900, and It's the Closest Thing You'll Get to a Guarantee on Wall Street
Short-term moves in Wall Street's major indexes are impossible to predict with concrete accuracy. Perspective is everything ...
Altimmune's Catalytic Moment In 2025: Pemvidutide's Phase 2b Trial In MASH
Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...
H.C. Wainwright cuts Compass Pathways stock target to $45
H.C. Wainwright analyst Patrick Trucchio revised the price target on Compass Pathways (NASDAQ:CMPS) stock, reducing it to $45 ...
Earnings call transcript: AIG Q4 2024 sees EPS beat, stock dips
American International Group Inc. (NYSE:AIG) reported its fourth-quarter 2024 earnings, posting an earnings per share (EPS) of $1.30, slightly surpassing the forecast of $1.28. Revenue for the quarter ...
Denny's: Still In The Penalty Box
Denny's Corporation faces ongoing challenges like competition, rising costs, and weak growth outlook for 2025. Read why DENN ...